Literature DB >> 26913730

Insulin-Treated Patients with Diabetes Mellitus Undergoing Emergency Abdominal Surgery Have Worse Outcomes than Patients Treated with Oral Agents.

Tobias Haltmeier1, Elizabeth Benjamin1, Elizabeth Beale2, Kenji Inaba1, Demetrios Demetriades3.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is a known risk factor for worse outcomes after emergency abdominal surgery (EAS). However, it is unclear if the type of diabetes treatment (insulin or oral agents) has any effect on outcomes after EAS.
METHODS: Matched cohort study utilizing the ACS NSQIP database. Patients with DM undergoing EAS were divided into insulin and oral agent treatment groups. A 1:1 cohort matching of insulin-treated and oral agent-treated patients was performed (matched for sex, age, ASA score, BMI category, operative procedure, and preoperative acute renal failure, pneumonia, SIRS, sepsis, septic shock, and corticosteroid use). Outcomes of matched insulin- and oral agent-treated patients were compared with univariable and multivariable regression analysis.
RESULTS: A total of 7401 patients with DM underwent EAS, 3182 (43 %) of which were insulin treated and 4219 (57 %) were treated with oral agents. Matching resulted in 2280 matched cases, which formed the basis of this analysis. Insulin-treated patients were more likely to have postoperative complications (OR 1.279, CI 1.119-1.462), had a higher 30-day mortality rate in patients with sepsis at hospital admission (OR 3.421, CI 1.959-5.974), and a longer total hospital length of stay (RC 1.115, CI 1.065-1.168) and postoperative LOS (RC 1.082, CI 1.031-1.135).
CONCLUSIONS: In patients with DM undergoing emergency abdominal surgery, insulin-treated patients have worse outcomes than oral agent-treated patients. Insulin-treated patients with DM therefore should be monitored and treated more intensively in anticipation of potential complications after emergency abdominal surgery.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26913730     DOI: 10.1007/s00268-016-3469-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

1.  Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.

Authors:  Chase Watters; Jake A Everett; Cecily Haley; Allie Clinton; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

2.  Effect of delaying same-admission cholecystectomy on outcomes in patients with diabetes.

Authors:  R Gelbard; E Karamanos; P G Teixeira; E Beale; P Talving; K Inaba; D Demetriades
Journal:  Br J Surg       Date:  2013-12-16       Impact factor: 6.939

3.  The effect of diabetes mellitus on in-hospital and long-term outcomes after heart valve operations.

Authors:  Michael E Halkos; Patrick Kilgo; Omar M Lattouf; John D Puskas; William A Cooper; Robert A Guyton; Vinod H Thourani
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

4.  Diabetes mellitus and cerebrovascular disease as independent determinants for increased hospital costs and length of stay in open appendectomy in comparison with laparoscopic appendectomy: a nationwide cohort study.

Authors:  Chun-Chieh Yeh; Chi-Hsun Hsieh; Chien-Chang Liao; Li-Ting Su; Yu-Chun Wang; Tsai-Chung Li
Journal:  Am Surg       Date:  2012-03       Impact factor: 0.688

5.  Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus.

Authors:  N Mito; T Hiyoshi; T Hosoda; C Kitada; K Sato
Journal:  Eur J Clin Nutr       Date:  2002-04       Impact factor: 4.016

6.  The impact of diabetes on outcome in traumatically injured patients: an analysis of the National Trauma Data Bank.

Authors:  Lillian S Kao; S Rob Todd; Frederick A Moore
Journal:  Am J Surg       Date:  2006-12       Impact factor: 2.565

7.  Complications of coronary artery surgery in diabetic patients.

Authors:  R Fietsam; J Bassett; J L Glover
Journal:  Am Surg       Date:  1991-09       Impact factor: 0.688

Review 8.  Glargine safety, diabetes and cancer.

Authors:  Marc Rendell; Halis Kaan Akturk; Sri Harsha Tella
Journal:  Expert Opin Drug Saf       Date:  2013-02-11       Impact factor: 4.250

9.  Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus.

Authors:  W A Pulsinelli; D E Levy; B Sigsbee; P Scherer; F Plum
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

10.  Risk factors of postoperative infections in adults with complicated appendicitis.

Authors:  Poon Chi Ming; Tsang Yvonne Yee Yan; Leong Heng Tat
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2009-06       Impact factor: 1.719

View more
  4 in total

Review 1.  Debate on Insulin vs Non-insulin Use in the Hospital Setting-Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?

Authors:  Francisco J Pasquel; Maya Fayfman; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2019-07-29       Impact factor: 4.810

2.  Preadmission Insulin-Treated Type 2 Diabetes Mellitus Patients Had Increased Mortality in Intensive Care Units.

Authors:  Rongping Fan; Lei Xie; Xuemin Peng; Bo Yu; Huajie Zou; Jiaojiao Huang; Xuefeng Yu; Daowen Wang; Yan Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-22       Impact factor: 3.249

3.  Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.

Authors:  Bo Yu; Chenze Li; Yang Sun; Dao Wen Wang
Journal:  Cell Metab       Date:  2020-11-23       Impact factor: 27.287

4.  Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Chengxia Kan; Yang Zhang; Fang Han; Qian Xu; Tongtong Ye; Ningning Hou; Xiaodong Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-16       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.